BioCentury
ARTICLE | Company News

TopiVert, J&J deal

December 12, 2011 8:00 AM UTC

TopiVert partnered with RespiVert Ltd. to discover and develop narrow-spectrum kinase inhibitors using IP from RespiVert, which was acquired by Johnson & Johnson in 2010. TopiVert will receive exclus...